All posts tagged "CELZ"

BioPharma2 days ago

Brainstorm Cell Therapeutics’ (NASDAQ: BCLI) Post-Setback Resurgence: Unpacking FDA Impact & Market Expectations

Energy & Resources3 days ago

iSun, Inc (NASDAQ: ISUN) on the Rise: Recent Market Growth & Remarkable Momentum

Featured4 days ago

Uncovering CS Diagnostics (OTC: FZRO): Behind the 117% Gain & Market Opportunity

BioPharma5 days ago

Apollomics (NASDAQ: APLM) Market Momentum: Pipeline Potential, Market Trends, and Retail Insights

BioPharma1 week ago

Processa Pharmaceuticals (NASDAQ: PCSA): Revolutionizing Cancer Treatment through Next-Generation Chemotherapies

Featured2 weeks ago

Boardroom Battles and AI Fears: The OpenAI Story Unfolded

Featured2 weeks ago

AB International Group (OTC: ABQQ) Beyond the Numbers: Strategic Evolution in the Entertainment Industry

Featured3 weeks ago

Star Alliance International (OTC:STAL): Unpacking the 340% Gain & Future Prospects

Emerging Markets3 weeks ago

Music Licensing Inc. (OTC: SONG): Unraveling the 1250% Surge and Current Valuation

Featured3 weeks ago

Novo Integrated Sciences (NASDAQ: NVOS): From 350% Peaks to Controversial Shifts and Potential Catalysts

Featured4 weeks ago

TG Therapeutics (NASDAQ: TGTX): Bullish Analysts & Breakthrough Treatment in Relapsing MS

Energy & Resources4 weeks ago

BlueFire Technology Corp. (OTC: BLFR): Bold Ambitions & Path to NASDAQ Uplisting

Featured1 month ago

A2Z Smart Technologies (NASDAQ: AZ): Unveiling the Future of Shopping & Global Expansion

Featured1 month ago

3DX Industries (OTC: DDDX): Revolutionizing Manufacturing & Government Contracts

Featured1 month ago

FingerMotion (NASDAQ: FNGR): Latest Developments and Ongoing Investigations

Energy & Resources1 month ago

“Nouveau Monde Graphite (NYSE: NMG): Leveraging China’s Restrictions on Graphite Exports

BioPharma1 month ago

SAB Biotherapeutics (NASDAQ: SABS): Makes Strides in Type 1 Diabetes

Featured1 month ago

Galera Therapeutics (NASDAQ: GRTX) in Focus: Exploring Catalysts Ahead of FDA’s Verdict

BioPharma2 months ago

Nkarta Inc. (NASDAQ: NKTX): Breakthrough in NK Cell Therapy for Lupus Nephritis

Featured2 months ago

Astra Energy (OTCQB: ASRE): Pioneering Renewable Power and Market Momentum

Featured2 months ago

Meta Materials’ (NASDAQ:MMAT) Journey: Legal Hurdles, Innovation and Future Potential

BioPharma2 months ago

Tempest Therapeutics (NASDAQ: TPST) Soars 2,879%: From Downturn to Breakthrough in Clinical Trials

Featured2 months ago

Splash Beverage’s (NYSE: SBEV) Meteoric Surge: Can It Rival Beverage Industry Giants?

Featured2 months ago

Clean Vision Corporation (OTC: CLNV): Understanding the 180% Surge and Key Insights

Featured2 months ago

Orchard Therapeutics’ (NASDAQ: ORTX) Shares Skyrocket: How To Predict Biotech M&A

BioPharma2 months ago

Vivos Therapeutics (NASDAQ: VVOS) Strategic Moves: A Step Forward in Sleep Disorder Solutions

Featured2 months ago

IceCure Medical’s (NASDAQ: ICCM) ProSense: A 96.8% Success Rate Revolutionizing Breast Cancer Treatment

Featured2 months ago

T2 Biosystems (NASDAQ: TTOO) Breaks Ground: FDA Clearance, Market Trends, and Healthcare Impact

BioPharma2 months ago

Organogenesis (NASDAQ: ORGO): Latest Developments and Future Growth Prospects

Featured2 months ago

Femasys’ (NASDAQ: FEMY) FemaSeed Receives FDA Nod: A Game-Changer for Infertility Treatment

BioPharma2 months ago

Vaccitech (NASDAQ: VACC) Gains Unprecedented Support—What’s Behind It?

Featured2 months ago

MSP Recovery (NASDAQ: LIFW) in the Spotlight: Legal Battles, Luxe Living, and Stock Surge

Featured2 months ago

Solowin Holdings (NASDAQ: SWIN) 95% Stock Rally: Analyzing the Market Hype and IPO Impact”

BioPharma2 months ago

Advancing Medical Frontiers: Elutia Inc.’s(NASDAQ: ELUT) Strategic Vision in a $600 Million Market

Featured2 months ago

FingerMotion, Inc. (NASDAQ: FNGR): A Closer Look at its 500% Surge

Featured3 months ago

Navigating the Green Wave: US Cannabis ETF (NYSE: MSOS) A Closer Look at Cannabis Stock Resurgence

Featured3 months ago

First Wave BioPharma’s (NASDAQ: FWBI) Exclusive License: Repurposing Capeserod for GIT Disorder Solutions

BioPharma3 months ago

ZyVersa Therapeutics’ (NASDAQ: ZVSA) Breakthrough: A Super Tool for Tackling Inflammation in ALS and Beyond

BioPharma3 months ago

Creative Medical Technology NASDAQ: CELZ) Major Breakthrough: Allogeneic Cell Line Paves the Way for Diabetes Treatment

Featured3 months ago

Aurora Cannabis (NASDAQ: ACB) Focuses on Debt Reduction and Positive Cash Flow Amidst Flourishing Cannabis Industry

Emerging Markets3 months ago

Lucy Scientific Discovery’s (NASDAQ: LSDI) Game-Changing Move: A Closer Look at the High Times Acquisition

BioPharma3 months ago

Axcella Therapeutics’ (NASDAQ: AXLA) Patent Triumph: A Milestone for Global IP Position

Featured3 months ago

NeuBase Therapeutics (NASDAQ: NBSE) Stake Acquisition: Symetryx Urges Board to Consider $1 per Share Dividend

Emerging Markets3 months ago

WM Technology’s (NASDAQ: MAPS) Stock Surges 91% in Mysterious Rally: What’s Behind the Boom?

Emerging Markets3 months ago

Cannabis Industry Surges: Flora Growth Corp. (NASDAQ: FLGC) Leads the Way with 77% Intraday Jump

BioPharma3 months ago

Virios Therapeutics (NASDAQ: VIRI) Advances Promising Antiviral Therapies for Chronic Diseases: Latest Momentum and Pipeline Developments

Emerging Markets3 months ago

Analyzing the Phenomenal Surge: iCoreConnect’s (OTCQB: ICCT) Explosive Growth After Merger

Featured3 months ago

Sunlands Technology’s (NYSE: STG) Remarkable Turnaround: Q2 2023 Sees Net Income Soar and Robust Growth

Emerging Markets3 months ago

Nikola’s Road to Redemption: From Sky-High Debut to Recent Resurgence

Featured3 months ago

Genius Group (NYSE: GNS) Short Squeeze: Recent Developments and What Investors Should Know

BioPharma2 days ago

Brainstorm Cell Therapeutics’ (NASDAQ: BCLI) Post-Setback Resurgence: Unpacking FDA Impact & Market Expectations

Energy & Resources3 days ago

iSun, Inc (NASDAQ: ISUN) on the Rise: Recent Market Growth & Remarkable Momentum

Featured4 days ago

Uncovering CS Diagnostics (OTC: FZRO): Behind the 117% Gain & Market Opportunity

Uncategorized12 months ago

Meta Materials Inc (OTCMKTS: MMTLP) Enormous Short Position in Trouble as Next Bridge Hydrocarbons Set to Stop Trading (George Palikaras & John Brda on Corporate Action)

Micro Cap Insider2 years ago

Medium (KOK PLAY) The Parabolic Rise of Metal Arts (OTCMKTS: MTRT)

Media & Technology3 years ago

Healthier Choices Management Corp. (OTCMKTS: HCMC) Powerful Comeback Brewing as PMI Patent Infringement Lawsuit Moves Forward